U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07474727) titled 'A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer' on March 05.
Brief Summary: This study is an open, multi-center, phase II study, aiming to evaluate the safety, tolerability and efficacy of AMT-676 combined with 5-fluorouracil, leucovorin, bevacizumab (or cetuximab) in participants with advanced colorectal cancer, and to assess the PK(Pharmacokinetic) characteristics and immunogenicity of AMT-676.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Colorectal Cancer
Intervention:
DRUG: AMT-676
Patients will get different dose levels treatment of AMT-676. AMT-676 will be Administer...